IT1244728B - Impiego medicamentoso di derivati diidropiridinici - Google Patents

Impiego medicamentoso di derivati diidropiridinici

Info

Publication number
IT1244728B
IT1244728B ITMI910359A ITMI910359A IT1244728B IT 1244728 B IT1244728 B IT 1244728B IT MI910359 A ITMI910359 A IT MI910359A IT MI910359 A ITMI910359 A IT MI910359A IT 1244728 B IT1244728 B IT 1244728B
Authority
IT
Italy
Prior art keywords
medical use
dihydropyridine derivatives
preparation
drugs
pyridinbicarboxylic
Prior art date
Application number
ITMI910359A
Other languages
English (en)
Inventor
Giovanni Gaviraghi
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of ITMI910359A0 publication Critical patent/ITMI910359A0/it
Priority to ITMI910359A priority Critical patent/IT1244728B/it
Priority to DE69221649T priority patent/DE69221649T2/de
Priority to AU12231/92A priority patent/AU646929B2/en
Priority to UA93004263A priority patent/UA27780C2/uk
Priority to EP92102146A priority patent/EP0499920B1/en
Priority to JP4503957A priority patent/JP2996725B2/ja
Priority to ES92102146T priority patent/ES2106098T3/es
Priority to PCT/EP1992/000276 priority patent/WO1992014460A1/en
Priority to CA002103805A priority patent/CA2103805C/en
Priority to RU93054780A priority patent/RU2136279C1/ru
Priority to DK92102146.5T priority patent/DK0499920T3/da
Priority to SG1996007490A priority patent/SG59972A1/en
Priority to CS931650A priority patent/CZ281760B6/cs
Priority to EP92903946A priority patent/EP0576433A1/en
Priority to AT92102146T priority patent/ATE157004T1/de
Priority to US08/094,150 priority patent/US5455257A/en
Priority to MX9200600A priority patent/MX9200600A/es
Priority to PH43915A priority patent/PH30130A/en
Priority to IE045392A priority patent/IE920453A1/en
Priority to IL10092892A priority patent/IL100928A/xx
Priority to ZA921006A priority patent/ZA921006B/xx
Publication of ITMI910359A1 publication Critical patent/ITMI910359A1/it
Priority to KR1019930702402A priority patent/KR100188171B1/ko
Priority to NO932874A priority patent/NO303713B1/no
Application granted granted Critical
Publication of IT1244728B publication Critical patent/IT1244728B/it
Priority to GR970402303T priority patent/GR3024661T3/el
Priority to HK98110314A priority patent/HK1009585A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un derivato diidropiridinico è utilizzato, in miscela con eccipienti o veicoli di uso farmaceutico, nella preparazione di farmaci attivi contro disturbi cardiovascolari. In particolare è descritto l'uso dell'estere dietilico dell'acido (E) -4-[2[3-(1, 1-dimetiletossi)-3-osso-1-propenil]fenil]-1, 4-diidro-2, 6-dimetil-3, 5-piridinbicarbossilico nella preparazione di farmaci utili nella prevenzione e nel trattamento dell'aterosclerosi e dell'arteriosclerosi, nonché di forme morbose ad esse associate.
ITMI910359A 1991-02-13 1991-02-13 Impiego medicamentoso di derivati diidropiridinici IT1244728B (it)

Priority Applications (25)

Application Number Priority Date Filing Date Title
ITMI910359A IT1244728B (it) 1991-02-13 1991-02-13 Impiego medicamentoso di derivati diidropiridinici
CS931650A CZ281760B6 (cs) 1991-02-13 1992-02-08 Použití diethylesteru kyseliny (E)-4-/2-/3-(1,1-dimethylethosy)-3-oxo-1-propenyl/fenyl/-1,4-dihydr o-2,6-dimethyl-3,5-pyridindikarboxylové pro výrobu farmaceutických prostředků pro léčení nebo....
AT92102146T ATE157004T1 (de) 1991-02-13 1992-02-08 Lacidipin zur behandlung der arteriosklerosis
UA93004263A UA27780C2 (uk) 1991-02-13 1992-02-08 Діюча речовина лікарського засобу для лікування або профілактики артеріосклерозу та/або асоційованих з ним серцево-судинних захворювань, спосіб лікування або профілактики артеріосклерозу у ссавців та лікарський засіб, що в ньому використовується
EP92102146A EP0499920B1 (en) 1991-02-13 1992-02-08 Lacidipine for the treatment of arteriosclerosis
JP4503957A JP2996725B2 (ja) 1991-02-13 1992-02-08 動脈硬化の治療のためのラシジピンの使用
ES92102146T ES2106098T3 (es) 1991-02-13 1992-02-08 Lacidipino para el tratamiento de la arteriosclerosis.
PCT/EP1992/000276 WO1992014460A1 (en) 1991-02-13 1992-02-08 Use of lacidipine for the treatment of arteriosclerosis
CA002103805A CA2103805C (en) 1991-02-13 1992-02-08 Use of lacidipine for the treatment of arteriosclerosis
RU93054780A RU2136279C1 (ru) 1991-02-13 1992-02-08 Применение лацидипина для лечения артериосклероза
DK92102146.5T DK0499920T3 (da) 1991-02-13 1992-02-08 Lacidipin til behandling af arteriosclerosis
SG1996007490A SG59972A1 (en) 1991-02-13 1992-02-08 Medicaments
DE69221649T DE69221649T2 (de) 1991-02-13 1992-02-08 Lacidipin zur Behandlung der Arteriosklerosis
EP92903946A EP0576433A1 (en) 1991-02-13 1992-02-08 Use of lacidipine for the treatment of arteriosclerosis
AU12231/92A AU646929B2 (en) 1991-02-13 1992-02-08 Use of lacidipine for the treatment of arteriosclerosis
US08/094,150 US5455257A (en) 1991-02-13 1992-02-08 Lacidipine for the treatment of arteriosclerosis
MX9200600A MX9200600A (es) 1991-02-13 1992-02-12 Medicamento que contiene lacidipina, para el tratamiento o prevencion de arteriosclerosis.
PH43915A PH30130A (en) 1991-02-13 1992-02-12 Lacidipine for the treatment of arteriosclerosis
IE045392A IE920453A1 (en) 1991-02-13 1992-02-12 Medicaments
IL10092892A IL100928A (en) 1991-02-13 1992-02-12 Use of lacidipine for the preparation of pharmaceutical compositions for the treatment and/or prevention of arteriosclerosis
ZA921006A ZA921006B (en) 1991-02-13 1992-02-12 Medicaments
KR1019930702402A KR100188171B1 (en) 1991-02-13 1993-08-12 Use of lacidipine for the treatment of arteriosclerosis
NO932874A NO303713B1 (no) 1991-02-13 1993-08-12 Anvendelse av lacidipin for behandling av arteriosklerose
GR970402303T GR3024661T3 (en) 1991-02-13 1997-09-09 Lacidipine for the treatment of arteriosclerosis
HK98110314A HK1009585A1 (en) 1991-02-13 1998-08-31 Lacidipine for the treatment of arteriosclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910359A IT1244728B (it) 1991-02-13 1991-02-13 Impiego medicamentoso di derivati diidropiridinici

Publications (3)

Publication Number Publication Date
ITMI910359A0 ITMI910359A0 (it) 1991-02-13
ITMI910359A1 ITMI910359A1 (it) 1992-08-13
IT1244728B true IT1244728B (it) 1994-08-08

Family

ID=11358541

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI910359A IT1244728B (it) 1991-02-13 1991-02-13 Impiego medicamentoso di derivati diidropiridinici

Country Status (24)

Country Link
US (1) US5455257A (it)
EP (2) EP0499920B1 (it)
JP (1) JP2996725B2 (it)
KR (1) KR100188171B1 (it)
AT (1) ATE157004T1 (it)
AU (1) AU646929B2 (it)
CA (1) CA2103805C (it)
CZ (1) CZ281760B6 (it)
DE (1) DE69221649T2 (it)
DK (1) DK0499920T3 (it)
ES (1) ES2106098T3 (it)
GR (1) GR3024661T3 (it)
HK (1) HK1009585A1 (it)
IE (1) IE920453A1 (it)
IL (1) IL100928A (it)
IT (1) IT1244728B (it)
MX (1) MX9200600A (it)
NO (1) NO303713B1 (it)
PH (1) PH30130A (it)
RU (1) RU2136279C1 (it)
SG (1) SG59972A1 (it)
UA (1) UA27780C2 (it)
WO (1) WO1992014460A1 (it)
ZA (1) ZA921006B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006113309A1 (en) * 2005-04-15 2006-10-26 Dr. Reddy's Laboratories Ltd. Lacidipine particles
WO2007096694A1 (es) * 2006-02-22 2007-08-30 Ramiro Vergara Asociacion de principios activos neuroactivadores

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597163A (ja) * 1982-07-02 1984-01-14 Yamanouchi Pharmaceut Co Ltd 抗動脈硬化剤
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions
GB8431119D0 (en) * 1984-12-10 1985-01-16 Fujisawa Pharmaceutical Co Anti-arteriosclerotic composition

Also Published As

Publication number Publication date
ITMI910359A1 (it) 1992-08-13
WO1992014460A1 (en) 1992-09-03
US5455257A (en) 1995-10-03
IL100928A (en) 1997-02-18
MX9200600A (es) 1992-10-30
CZ165093A3 (en) 1994-03-16
CZ281760B6 (cs) 1997-01-15
NO932874L (no) 1993-08-12
AU1223192A (en) 1992-09-15
ZA921006B (en) 1992-12-30
DK0499920T3 (da) 1998-01-26
RU2136279C1 (ru) 1999-09-10
JP2996725B2 (ja) 2000-01-11
AU646929B2 (en) 1994-03-10
CA2103805A1 (en) 1992-08-14
IE920453A1 (en) 1992-08-12
EP0499920A1 (en) 1992-08-26
GR3024661T3 (en) 1997-12-31
CA2103805C (en) 2002-09-17
EP0576433A1 (en) 1994-01-05
NO932874D0 (no) 1993-08-12
NO303713B1 (no) 1998-08-24
DE69221649D1 (de) 1997-09-25
ES2106098T3 (es) 1997-11-01
HK1009585A1 (en) 1999-06-04
PH30130A (en) 1997-01-21
UA27780C2 (uk) 2000-10-16
ATE157004T1 (de) 1997-09-15
EP0499920B1 (en) 1997-08-20
KR100188171B1 (en) 1999-06-01
DE69221649T2 (de) 1997-12-11
ITMI910359A0 (it) 1991-02-13
JPH06505002A (ja) 1994-06-09
SG59972A1 (en) 1999-02-22

Similar Documents

Publication Publication Date Title
DE69331409D1 (de) Oral 1alpha-hydroxyprevitamin d
TW262461B (it)
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
ES2045182T3 (es) Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen.
ATE121295T1 (de) Augentropfenarzneimittel.
DK515489D0 (da) Dispergerbar laegemiddelformulering
IT1235153B (it) Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento
MX10059A (es) Procedimiento para la preparacion de antagonistas de leucotrienos novedosos y producto obtenido
DE68923169D1 (de) Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
ES2059816T3 (es) Sustancias activas fisiologicamente, un procedimiento para la preparacion y composiciones farmaceuticas de las mismas.
NO944531L (no) Diaminsalter av clavulansyre
BG60101B2 (bg) Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
IT1244728B (it) Impiego medicamentoso di derivati diidropiridinici
ES2108680T3 (es) Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
CA2120001A1 (en) Flavopereirine-based pharmaceutical composition and use thereof for treating hiv
CA2119777A1 (en) An Ameliorant for Blood Lipid Metabolism
ATE210445T1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
ATE210985T1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
ITMI912027A0 (it) Derivati dell'eserolina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI911713A0 (it) Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI911841A0 (it) Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI911842A0 (it) Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
UA30143C2 (uk) Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань
ATE130190T1 (de) Ein dihydropyridinderivat in nanosolform enthaltendes retard-arzneimittel und seine herstellung.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970227